For example, blocking ERK activation in claudin-low cell lines by MEK inhibitors or by forced expression of DUSP4, dual specificity phosphatase-4 that is a negative regulator of ERK, has been shown to reduce the CD44hi/CD24-/lo populations in vitro and to diminish tumor initiating populations in vivo [54]. This evidence concerns the gene MAP2K7 and neoplasm.